Gevo Inc
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
GEVO$1.39-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In thousands)
| | | | | | | | | |
|---|---|---|---|---|---|---|---|---|
| · · · · Year Ended December 31, | ||||||||
| · Note · · 2023 · 2022 | ||||||||
| Operating Activities · · · | ||||||||
| Net loss | | $(66,215) | | $(98,007) | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | | | ||||||
| Impairment loss | 4 | | — | | 24,749 | |||
| Loss on disposal of assets | 23 | | — | | 499 | |||
| Stock-based compensation | 16 | | 17,087 | | 17,419 | |||
| Depreciation and amortization | 11, 12 | | 19,007 | | 7,887 | |||
| Amortization of marketable securities (discount) premium | 6 | | (102) | | 2,723 | |||
| Other noncash expense (income) | | 908 | | 877 | ||||
| Changes in operating assets and liabilities: | | | | | | |||
| Accounts receivable | | (2,147) | | 502 | ||||
| Inventories | 10 | | 670 | | (2,004) | |||
| Prepaid expenses and other current assets, deposits and other assets | 8, 13 | | (25,620) | | (2,591) | |||
| Accounts payable, accrued expenses and non-current liabilities | 14 | | 2,693 | | 3,635 | |||
| Net cash used in operating activities | | (53,719) | | (44,311) | ||||
| Investing Activities | | | ||||||
| Acquisitions of property, plant and equipment | 11, 23 | | (54,455) | | (84,077) | |||
| Acquisition of patent portfolio | 12 | | — | | (10) | |||
| Proceeds from maturity of marketable securities | 6 | | 168,550 | | 299,581 | |||
| Purchase of marketable securities | 6 | | — | | (130,402) | |||
| Proceeds from sale of property, plant and equipment | | 11 | | | 34 | | | — |
| Net cash provided by investing activities | | 114,129 | | 85,092 | ||||
| Financing Activities | | | ||||||
| Debt and equity offering costs | 21 | | — | | (10,993) | |||
| Proceeds from issuance of common stock and common stock warrants | 21 | | — | | 150,000 | |||
| Proceeds from exercise of warrants | 21 | | — | | 3 | |||
| Net settlement of common stock under stock plans | 16 | | — | | (286) | |||
| Payment of loans payable | 15 | | (167) | | (150) | |||
| Payment of finance lease liabilities | 9 | | (22) | | (12) | |||
| Net cash (used in) provided by financing activities | | (189) | | 138,562 | ||||
| Net increase in cash and cash equivalents | | 60,221 | | 179,343 | ||||
| Cash, cash equivalents and restricted cash at beginning of period | | 315,376 | | 136,033 | ||||
| Cash, cash equivalents and restricted cash at end of period | | $375,597 | | $315,376 | ||||
(In thousands)
| · · · · · · | ||||
|---|---|---|---|---|
| · · Year Ended December 31, | ||||
| Schedule of cash, cash equivalents and restricted cash · · 2023 · 2022 | ||||
| Cash and cash equivalents | | $298,349 | | $237,125 |
| Restricted cash (current) | | 77,248 | | 1,032 |
| Restricted cash (non-current) | | — | | 77,219 |
| Total cash, cash equivalents and restricted cash | | $375,597 | | $315,376 |
| · · · · · · | ||||
|---|---|---|---|---|
| · · Year Ended December 31, | ||||
| Supplemental disclosures of cash and non-cash investing and financing transactions · · 2023 · 2022 | ||||
| Cash paid for interest, net of amounts capitalized | | $1,029 | | $522 |
| Non-cash purchase of property, plant and equipment | | 8,174 | | 13,837 |
| Right-of-use asset purchased with operating lease | | 199 | | — |
Notes to Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.